CSF rhinorrhea: detection and localization using overpressure cisternography with Tc-99m-DTPA.
We performed 32 overpressure radionuclide cisternography (ORNC) studies to examine 26 patients who were clinically suspected of having cerebrospinal fluid (CSF) fistula with rhinorrhea. Fifteen (47%) of these cisternography studies were positive, and the site of the leak was identified. No leak could be demonstrated in the other 17. Of 23 examinations performed in patients who had clinically documented CSF rhinorrhea, 15 (65%) were scintigraphically positive. The rapid cephalad transit of the radionuclide bolus allowed completion of the study within 30 to 45 minutes. Seven examinations were also performed with overpressure metrizamide CT cisternography (OMCTC), and five demonstrated concordant results with the radionuclide study. Patient discomfort and side effects were minimal. We conclude that radionuclide infusion cisternography is a safe, rapid, and accurate method of investigating a suspected or proven CSF rhinorrhea and that it is complementary to metrizamide cisternography.
D000328:Adult; D002559:Cerebrospinal Fluid Rhinorrhea / Q000000981:diagnostic imaging* / Q000209:etiology; D002946:Cisterna Magna / Q000000981:diagnostic imaging*; D005260:Female; D005402:Fistula / Q000000981:diagnostic imaging; D006801:Humans; D007427:Intracranial Pressure; D008297:Male; D008722:Methods; D008793:Metrizamide; D008875:Middle Aged; D004369:Pentetic Acid; D013667:Technetium; D016284:Technetium Tc 99m Pentetate; D014055:Tomography, Emission-Computed
D013667:Technetium; D004369:Pentetic Acid; D008793:Metrizamide; D016284:Technetium Tc 99m Pentetate